MedTrace Logo

A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery

NCT00586976 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2015-04-07

No results posted yet for this study

Summary

Cardiac surgery is associated with pain in the post-operative period. We plan to conduct a study of local anesthetic, ropivacaine, infusion into the sternal wound in adult patients undergoing cardiac surgery to see if it will be safe and result in improved pain control and reduced time to extubation, duration of ICU and hospital stay.

Conditions

  • Cardiac Surgery

Interventions

DRUG

Ropivacaine

0.3% ropivacaine infusion at 4 ml/hr for 64 hours.

DRUG

Normal saline

Normal saline infusion at 4 ml/hour for 64 hours.

Sponsors & Collaborators

  • Stryker Nordic

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Gregory A. Nuttall, M.D. · Mayo Clinic College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2007-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00586976 on ClinicalTrials.gov